ATP assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) and Geography: Global Market Size Estimates and Forecast (2022–2030)
The market crossed US$ 1.5 billion mark in 2022 and is expected to hit US$ 3.37 billion by 2030, recording a CAGR of 20.33% during the forecast period.
ATP assays market has been significantly growing with the growing demand for ATP assays in pharmaceutical companies.
Many pharmaceutical companies are investing in the growth of market. They are gaining regulatory approvals for cell culture-based vaccines that require the use of ATP assays in contamination testing, boosting the demand in the market. Contamination testing holds the maximum market share, which can be credited to the increasing regulatory stringency of pharmaceutical and food & beverage giants regarding non-contaminated production, rise in drug research after COVID-19, and the necessity for cleaning and disinfection of environmental surfaces in hospitals.
Within the report, the market is segmented into product, application, end-user, and geography. By products, the market is segmented into consumables (kits, reagent, microplate), and instrument (luminometer, spectrophotometers. On the basis of application, the market is segmented into the contamination, disease testing, and drug discovery. Based on end-user, the market is divided into hospitals, pharmaceuticals, and food testing. Geographically, the market is subsegmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Increasing food safety concerns will empower the growth during the forecast period.
Several companies and government organizations have made regulations to stipulate tolerable levels of contaminants, residues, and additives in food products to ensure high-quality products. It diminishes the risk of foodborne diseases, closures, and recalls and can also improve efficiency and reduce costs. Food production facilities depend on on ATP tests to see if the food-contact surfaces are cleaned. It also determines that the surfaces are free from risky microbial loads and must adhere to the safety and quality of the products.
Technological advancement in ATP assay probes is one of the major opportunities for market growth.
The characterization of ATP dynamics provides valuable mechanistic insights into processes ranging from neurotransmission to immune cell chemotaxis. Thus, there is a necessity for a methodology to interrogate the temporal and spatial components of ATP dynamics from the subcellular to organismal levels in live specimens. From last few years, several molecular probes specific for ATP have been launched. These probes have been joint with imaging approaches, particularly optical microscopy, to enable this critical molecule's qualitative and quantitative detection.
Recent strategic developments in ATP assays market
The ATP aasays market has undergone several significant developments, and a few of these have been mentioned below:
- In 2021, Abcam doubled the footprint of its immunoassay kit R&D and manufacturing facility in Eugene, Oregon.
- In 2020, Merck broadened its industrial footprint with a combined investment of USD 44.2 million (EUR 40 million) at its manufacture services in Danvers, Massachusetts, and Jaffrey, New Hampshire. These sites supply essential products to customers developing lifesaving therapies, including COVID-19 vaccines, and provide biopharmaceutical manufacturing products and services.
- In 2019, Merck opened M Lab Collaboration Center in France, which delivers biopharmaceutical manufacturers access Merck's Life Science product portfolio. This aided in product branding and in increasing Merck's presence in Europe.
Several players drive the ATP aasays market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, NEOGEN Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology, Inc. among others are among the prominent players operating in the market.
Target audience for the report:
- Drug developing companies
- Contract development and manufacturing organization,
- Drug discovery-related associations, organizations, forums, and alliances
- Government bodies, such as regulating authorities and policymakers
- Venture capitalists, private equity firms, and start-up companies
- Drug distributors and sales firms
- End users of drug discovery
- Research institutes, organizations, and consulting companies
Scope of the report:
In this report, the market has been segmented on the basis of:
- Products:
- Consumables
- Kits
- Reagents
- Microplate
- Instrument
- Luminometer
- Spectrophotometer
- Applications:
- Conatmination
- Disease testing
- Drug discovery
- End User:
- Hospitals
- Pharmaceuticals
- Food Testing
- Region
- North America
- Europe
- Asia Pacific (APAC)
- South & Central America
- Middle East & Africa
- Companies profiled
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Merck KGaA
- Danaher Corporation
- Elabscience Biotechnology Inc.
- Charm Sciences, Inc.
- Cell Signaling Technology
- Cayman Chemical
- Creative Bioarray
- BioThema AB
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Merck KGaA
- Danaher Corporation
- Elabscience Biotechnology Inc.
- Charm Sciences, Inc.
- Cell Signaling Technology
- Cayman Chemical
- Creative Bioarray
- BioThema AB